Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin potentials against viral infections including COVID-19: Current evidence and new findings
Kobra Bahrampour Juybari, Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, et al.
Virus Research (2020) Vol. 287, pp. 198108-198108
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Long covid—mechanisms, risk factors, and management
Harry Crook, Sanara Raza, Joseph Nowell, et al.
BMJ (2021), pp. n1648-n1648
Closed Access | Times Cited: 1462
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
Robert Root‐Bernstein
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 97
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants
Gilead Ebiegberi Forcados, Aliyu Muhammad, Olusola O. Oladipo, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 86
Safety of higher doses of melatonin in adults: A systematic review and meta‐analysis
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman, et al.
Journal of Pineal Research (2021) Vol. 72, Iss. 2
Open Access | Times Cited: 79
Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
Diseases (2020) Vol. 8, Iss. 4, pp. 44-44
Open Access | Times Cited: 78
A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19
M. R. S. Hawkins, Sanjeev Sockalingam, Sarah Bonato, et al.
Journal of Psychosomatic Research (2020) Vol. 141, pp. 110350-110350
Open Access | Times Cited: 76
Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial
Seyed Abbas Mousavi, Keyvan Heydari, Hossein Mehravaran, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 263-271
Open Access | Times Cited: 74
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
Saeed Mehrzadi, Mohammad Hossein Pourhanifeh, Alireza Mirzaei, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 64
SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin
Saeed Mehrzadi, Mohammad Yahya Karimi, Alireza Fatemi, et al.
Pharmacology & Therapeutics (2021) Vol. 224, pp. 107825-107825
Open Access | Times Cited: 61
Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc
Salvatore Corrao, Raffaella Mallaci Bocchio, Marika Lo Monaco, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1261-1261
Open Access | Times Cited: 61
Benefits and adverse events of melatonin use in the elderly (Review)
Lucreția Anghel, Liliana Baroiu, Corina Popazu, et al.
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 49
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments
Niaz Mahmud, Muzahidul I. Anik, M. Khalid Hossain, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 6, pp. 2431-2460
Closed Access | Times Cited: 46
Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions
Maria Anna Bantounou, Josip Plascevic, Helen F. Galley
Antioxidants (2022) Vol. 11, Iss. 3, pp. 532-532
Open Access | Times Cited: 42
Melatonin improves influenza virus infection-induced acute exacerbation of COPD by suppressing macrophage M1 polarization and apoptosis
Mengmeng Xu, Jia‐Ying Kang, Qiuyan Wang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
Suwen Hu, Songwei Jiang, Qi Xiang, et al.
Drug Development Research (2021) Vol. 83, Iss. 1, pp. 16-54
Open Access | Times Cited: 54
Tryptophan: A Unique Role in the Critically Ill
Marcela Káňová, Pavel Kohout
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11714-11714
Open Access | Times Cited: 52
Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights
Fang He, Xiaoyan Wu, Qingzhuo Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Yaser Pashaei
Journal of Clinical Neuroscience (2021) Vol. 88, pp. 163-172
Open Access | Times Cited: 43
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Rüssel J. Reiter, Ramaswamy Sharma, Fedor Šimko, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 35
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
Kenneth Maiese
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Melatonin Treatment in Kidney Diseases
Magdalena Markowska, Stanisław Niemczyk, Katarzyna Romejko
Cells (2023) Vol. 12, Iss. 6, pp. 838-838
Open Access | Times Cited: 17
Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment
Abdolkarim Hosseini, Hadi Esmaeili Gouvarchin Ghaleh, Hossein Aghamollaei, et al.
European Journal of Pharmacology (2021) Vol. 904, pp. 174193-174193
Open Access | Times Cited: 40
Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy
Kristina M. Cross, Dylan Landis, Laveena Sehgal, et al.
Endocrine Practice (2021) Vol. 27, Iss. 8, pp. 850-855
Open Access | Times Cited: 40
Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations
Xiaofeng Zhai, Ningning Wang, Houqi Jiao, et al.
Journal of Pineal Research (2021) Vol. 71, Iss. 2
Open Access | Times Cited: 40
A Pilot Study on Controlling Coronavirus Disease 2019 (COVID-19) Inflammation Using Melatonin Supplement
Zahra Alizadeh, Nastaran Keyhanian, Sara Ghaderkhani, et al.
Iranian Journal of Allergy Asthma and Immunology (2021)
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top